Avaleht/Aktsiad/CNSP

CNSP

USD

CNS Pharmaceuticals Inc. Common Stock

$6.600-0.420 (-5.983%)

Reaalajas hind

Healthcare

Biotehnoloogia

Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad

Ettevõtte fundamentaalnäitajad

Kauplemisstatistika

Turunäitajad

Avatud

$7.020

Kõrge

$7.020

Madal

$6.500

Maht

0.01M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

3.8M

Tööstusharu

Biotehnoloogia

Riik

United States

Kauplemisstatistika

Keskmine maht

0.05M

Börs

NCM

Valuuta

USD

52 nädala vahemik

Madal $4.93Praegune $6.600Kõrge $114

Seotud uudised

12. sept 2025 · 14:08

Analyst Upgrades

Maxim Group Upgrades CNS Pharma to Buy, Announces $20 Price Target

Maxim Group analyst Jason McCarthy upgrades CNS Pharma from Hold to Buy and announces $20 price target.

Vaata rohkem

Maxim Group Upgrades CNS Pharma to Buy, Announces $20 Price Target

3. sept 2025 · 13:15

AccessWire

CNS Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

HOUSTON, TX / ACCESS Newswire / September 3, 2025 / CNS Pharmaceuticals, Inc. , a biopharmaceutical company specializing in the development of novel treatments

Vaata rohkem

CNS Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

27. aug 2025 · 12:00

GlobeNewswire

IBN Announces Latest Episode of The BioMedWire Podcast Featuring John Climaco, CEO of CNS Pharmaceuticals Inc.

AUSTIN, Texas, Aug. 27, 2025 (GLOBE NEWSWIRE) -- -- via IBN -- IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of

Vaata rohkem